BR112014009946A2 - "composição, composição farmacêutica ou formulação purgativas e uso das mesmas" - Google Patents

"composição, composição farmacêutica ou formulação purgativas e uso das mesmas"

Info

Publication number
BR112014009946A2
BR112014009946A2 BR112014009946A BR112014009946A BR112014009946A2 BR 112014009946 A2 BR112014009946 A2 BR 112014009946A2 BR 112014009946 A BR112014009946 A BR 112014009946A BR 112014009946 A BR112014009946 A BR 112014009946A BR 112014009946 A2 BR112014009946 A2 BR 112014009946A2
Authority
BR
Brazil
Prior art keywords
compositions
water
soluble
purgatives
purgative
Prior art date
Application number
BR112014009946A
Other languages
English (en)
Inventor
Wettstein Antony
Saxon John
Ramrakha Sanjay
Julius Borody Thomas
Original Assignee
Salix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salix Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Inc
Publication of BR112014009946A2 publication Critical patent/BR112014009946A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

electrolyte purgatives the invention provides compositions for use in purgatives, for use as purgatives, and to methods for inducing purgation of the colon. in alternative embodiments, the invention provides compositions, e.g., a purgative, comprising: a water-soluble sodium salt (especially sodium sulphate), a water-soluble potassium salt (especially potassium sulphate), and a water-soluble magnesium salt (especially magnesium sulphate); and, compositions further comprising: a bisoxatin, or a detergent stool softening agent (such as sodium picosulphate) and/or a water-soluble sugar (such as xylose or equivalent); or, compositions having these ingredients at different amounts, but at equivalent proportions. in alternative embodiments, the invention provides purgative compositions comprising electrolytes, salts, sugars, bisoxatin, dyes and biofilm disruptors. ****************************** tradução do resumo resumo patente de invenção: "purgativos de eletrólitos". a invenção apresenta composições para o uso em purgativos, para o uso como purgativos, e os métodos para a indução de purgação do cólon. em modalidades alternativas, a invenção apresenta composições, por exemplo, um purgativo, o qual compreende: um sal de sódio solúvel em água (especialmente o sulfato de sódio), um sal de potássio solúvel em água (especialmente o sulfato de potássio), e um sal de sódio solúvel em água (especialmente o sulfato de magnésio); e composições, que também compreendem: uma bisoxatina, ou um agente amaciante de fezes detergente (tal como o picosulfato de sódio) e/ou um açúcar solúvel em água (tal como a xilose ou algo equivalente); ou composições que têm esses ingredientes em quantidades diferentes, mas em proporções equivalentes. em modalidades alternativas, a invenção apresenta composições purgativas que compreendem eletrólitos, sais, açúcares, bisoxatina, corantes e rompedores de biopelícula. 21111474v1 1/1 21111474v1
BR112014009946A 2011-10-27 2012-10-27 "composição, composição farmacêutica ou formulação purgativas e uso das mesmas" BR112014009946A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552431P 2011-10-27 2011-10-27
US201261717599P 2012-10-23 2012-10-23
PCT/AU2012/001315 WO2013059881A1 (en) 2011-10-27 2012-10-27 Electrolyte purgatives

Publications (1)

Publication Number Publication Date
BR112014009946A2 true BR112014009946A2 (pt) 2017-04-25

Family

ID=48166953

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009946A BR112014009946A2 (pt) 2011-10-27 2012-10-27 "composição, composição farmacêutica ou formulação purgativas e uso das mesmas"

Country Status (13)

Country Link
US (1) US20150056140A1 (pt)
EP (1) EP2782581A4 (pt)
JP (2) JP6240610B2 (pt)
KR (1) KR20140090217A (pt)
CN (1) CN104010642B (pt)
AU (2) AU2012327212B2 (pt)
BR (1) BR112014009946A2 (pt)
CA (1) CA2853520C (pt)
IL (1) IL232218B (pt)
IN (1) IN2014DN03373A (pt)
MX (1) MX352891B (pt)
RU (1) RU2640920C2 (pt)
WO (1) WO2013059881A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ611868A (en) 2010-12-13 2015-11-27 Salix Pharmaceuticals Inc Gastric and colonic formulations and methods for making and using them
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
PT2877163T (pt) 2012-07-27 2019-05-24 Redhill Biopharma Ltd Formulações e métodos de fabrico de formulações para utilização na evacuação colónica
ES2909386T3 (es) 2012-09-11 2022-05-06 Norgine Bv Composiciones que comprenden polietilenglicol y sulfatos de metales alcalinos o alcalinotérreos para su uso como composiciones de limpieza de colon
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
CN103585173B (zh) * 2013-10-28 2016-06-29 王显著 含硫酸钠和匹可硫酸的药物组合物
WO2016040733A1 (en) * 2014-09-12 2016-03-17 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
FR3049464B1 (fr) * 2016-03-29 2021-08-06 Marc Girard Preparations coliques
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR102127003B1 (ko) * 2017-10-12 2020-06-25 주식회사 한국팜비오 황산염을 포함하는 대장 하제 조성물
CN108244627A (zh) * 2018-01-16 2018-07-06 广西天昌投资有限公司 一种具有润肠功能的香蕉口服液及其制备方法
KR102111094B1 (ko) * 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물
RU2699222C1 (ru) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Солевой электролитный раствор для проведения энтеральных инфузий
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
KR20220122613A (ko) * 2019-12-23 2022-09-02 주식회사 비보존 대장 하제 조성물
KR20220033810A (ko) * 2020-09-10 2022-03-17 강윤식 장 정결용 보조 음료

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JP2000060487A (ja) * 1998-08-27 2000-02-29 Kao Corp 便秘改善剤
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
JP4458761B2 (ja) * 2003-03-27 2010-04-28 ロート製薬株式会社 瀉下用製剤
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
WO2008134071A1 (en) * 2007-04-26 2008-11-06 Theraquest Biosciences, Inc. Multimodal abuse resistant extended release formulations
WO2007057924A1 (en) * 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2008021394A2 (en) * 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
JP2008115085A (ja) * 2006-11-01 2008-05-22 Tendou Seiyaku Kk 緩下剤
US20090155363A1 (en) * 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
US20090258090A1 (en) * 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
JP2011135936A (ja) * 2009-12-25 2011-07-14 Toshiba Corp 画像処理装置、医用画像診断装置および画像処理プログラム
NZ611868A (en) * 2010-12-13 2015-11-27 Salix Pharmaceuticals Inc Gastric and colonic formulations and methods for making and using them
WO2012102799A2 (en) * 2011-01-28 2012-08-02 Shaver William A Method, composition and package for bowel cleansing

Also Published As

Publication number Publication date
JP2018008997A (ja) 2018-01-18
MX352891B (es) 2017-12-13
EP2782581A4 (en) 2015-05-20
IL232218A0 (en) 2014-06-30
KR20140090217A (ko) 2014-07-16
US20150056140A1 (en) 2015-02-26
AU2016213892A1 (en) 2016-09-01
AU2012327212A1 (en) 2013-05-23
WO2013059881A1 (en) 2013-05-02
JP2015510491A (ja) 2015-04-09
NZ723576A (en) 2018-07-27
AU2016213892B2 (en) 2018-04-05
CA2853520C (en) 2021-11-16
NZ624088A (en) 2016-09-30
CN104010642A (zh) 2014-08-27
IN2014DN03373A (pt) 2015-06-05
EP2782581A1 (en) 2014-10-01
CA2853520A1 (en) 2013-05-02
JP6240610B2 (ja) 2017-11-29
IL232218B (en) 2018-10-31
MX2014004962A (es) 2015-01-16
AU2012327212B2 (en) 2016-05-12
RU2014121255A (ru) 2015-12-10
RU2640920C2 (ru) 2018-01-12
CN104010642B (zh) 2018-08-17

Similar Documents

Publication Publication Date Title
BR112014009946A2 (pt) "composição, composição farmacêutica ou formulação purgativas e uso das mesmas"
BR112012017062A2 (pt) "composições deterfgentes contendo lipase de geobacillus stearothermophilus e métodos para uso das mesmas"
BR122020001787A8 (pt) Conjugado de anticorpo-agente ativo, seus métodos de preparação, sua composição e seu uso
BR112014032910A2 (pt) solfactants de éter de glicerina etoxilado
AR080457A1 (es) Limpiadores desinfectantes naturales
BR112015023648A2 (pt) revestimento de superfície reativo com propriedades de descontaminação química e biocidas
BR112014004687A2 (pt) imidazopiridazinas amino-substituídas
EA201200153A1 (ru) Сухая композиция для смешивания с водой (варианты), раствор для очищения кишечника на ее основе, водный раствор, набор, способ очищения толстой кишки
AR087845A1 (es) Articulos estables solubles en agua de dosis unitaria
PE20091312A1 (es) Producto para el cuidado oral y metodos de uso y fabricacion de los mismos
BRPI0915592A2 (pt) composto agonista do receptor de gpr119, processo para a preparação do composto, composição farmacêutica que o compreende, uso do mesmo e método para o tratamento ou profilaxia de diabetes mellitus do tipo ii
EA201190286A1 (ru) Адъювантные композиции, содержащие неионный агент, обеспечивающий изотоничность
BRPI0912290A8 (pt) Detergentes para pele e mãos.
CO6341618A2 (es) 4-fenil-1h-pirazoles insecticidas
BR112017022803A2 (pt) composição para limpeza com líquido iônico
BR112013016884A2 (pt) método para espessar uma formulação cosméticda com o uso de uma emulsão inchável de álcali de um polímero com amps e que é rico em ácido acrílico
BRPI0818541B8 (pt) composição farmacêutica que compreende grânulos incluindo picossulfato de sódio e bicarbonato de potássio e seu processo para a preparação
BRPI0908432A2 (pt) composições antimicrobianas tópicas
BR112013020101A2 (pt) composição emulsionável de limpeza de sabão concentrado
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
BRPI0916069C1 (pt) composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição
AR091606A1 (es) Composiciones orales de dentifrico y su uso en la fabricacion de un medicamento
CY1114043T1 (el) Συνθεσεις για τον καθαρισμο του εντερου και χρηση αυτων
BR112013017442A2 (pt) uso de compostos, composição para limpeza ou lavagem, composto, e, processo para preparar compostos
BR112014016115A2 (pt) produto de limpeza neutro para pavimentos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11T Dismissal of application maintained [chapter 11.20 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]